Related Experiment Video
Updated: Dec 27, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The role of programed death-ligand 1 in renal diseases
1Department of Nephrology, The Sixth affiliated hospital, Sun Yat-sen University, Guangzhou, China.
Abstract:
Programed death-ligand 1 (PD-L1, B7-H1, CD274) is a coinhibitory molecule that plays a vital role in the pathogenesis of both neoplastic and nonneoplastic diseases. However, the role of PD-L1 in primary and secondary renal diseases remains to be clarified. Previous studies have shown that both intracellular and intercellular PD-L1 participate in renal diseases via complex mechanisms. PD-L1 plays a dual role in lupus nephritis and has a protective effect in renal ischemia reperfusion injury and nephrotoxic nephritis but not in proliferative immune complex glomerulonephritis. PD-L1 supplementation, anti-PD-L1 antibodies, and D-peptide antagonists have promising application prospects in the treatment of renal diseases. In this review, we summarize the available data published on PD-L1 in renal diseases for the first time.
Insights
Programmed death-ligand 1 (PD-L1) impacts kidney diseases. This review clarifies PD-L1
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- Programmed death-ligand 1 (PD-L1) is a key coinhibitory molecule implicated in various diseases.
- The specific roles of PD-L1 in primary and secondary renal diseases require further elucidation.
- Both intracellular and intercellular PD-L1 mechanisms are involved in renal pathology.
Purpose of the Study:
- To comprehensively review and summarize existing literature on the role of PD-L1 in renal diseases.
- To clarify the complex mechanisms by which PD-L1 influences kidney pathology.
- To highlight potential therapeutic applications of targeting PD-L1 in renal conditions.
Main Methods:
- Systematic literature review of studies investigating PD-L1 in renal diseases.
- Analysis of data on PD-L1's involvement in different types of nephritis and kidney injuries.
- Evaluation of evidence regarding therapeutic strategies targeting PD-L1.
Main Results:
- PD-L1 exhibits a dual role in lupus nephritis.
- PD-L1 demonstrates a protective effect in renal ischemia reperfusion injury and nephrotoxic nephritis.
- PD-L1 does not appear to have a protective role in proliferative immune complex glomerulonephritis.
Conclusions:
- PD-L1's function in renal diseases is complex and context-dependent.
- Targeting PD-L1, through supplementation or antagonists, shows promise for treating renal diseases.
- Further research is warranted to fully understand and leverage PD-L1's therapeutic potential in nephrology.
More Related Videos
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Chronic Kidney Disease I: Introduction
Nephrons
Acute Kidney Injury II: Pathophysiology

